Clinical trials
Sexually Transmitted Infections (Not HIV or Hepatitis) clinical trials
Below are recruiting sexually transmitted infections (not hiv or hepatitis) clinical trials, each written for real people, not researchers. We’re tracking 778 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07378072Recruiting
12-week daytime eating study for fatty liver in obesity
This study tests if restricting eating to daytime hours for 12 weeks can reduce liver fat in people with obesity. It aims to help those with fatty liver disease improve their health without medication.
AngersAges 18–65 - NCT07378761RecruitingPhase 2
Comparing two drugs for liver inflammation from immunotherapy
This trial tests whether a bile acid pill (UDCA) works better than steroids for treating liver inflammation caused by immunotherapy cancer treatment. It may help patients who have moderate to severe liver side effects from their cancer drugs.
BordeauxAges 18 years+ - NCT07377175RecruitingPhase 1
Safety study of BSY001 in healthy adults
This early-phase trial tests a single or multiple doses of BSY001 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 50 who are not allergic to similar drugs and can avoid certain medicines and activities during the study.
HangzhouAges 18–50 - NCT07374185Recruiting
Bone marrow cells with Wharton gel for liver cirrhosis
This trial tests whether your own bone marrow cells, combined with a special gel from donated umbilical cords (Wharton's jelly exosomes), can help repair your liver. Researchers hope to improve liver function in people with cirrhosis.
Baghdad, IraqAges Up to 80 years - NCT07358546RecruitingPhase 1
Test of efimosfermin alfa in adults with liver problems
This trial is for adults with liver cirrhosis (scarring) who have moderate to severe liver impairment. It studies how the body handles a new medicine called efimosfermin alfa, to see if it could be a safe treatment option. You may be able to join if your liver function is stable and you fall into a specific Child-Pugh class.
Rialto, CaliforniaAges 18–70 - NCT07359586Recruiting
Laryngopharyngeal injury after breathing tube under anesthesia
This study looks at throat and voice box injuries that can happen after having a breathing tube during surgery. It may help doctors understand why some people experience hoarseness, sore throat, cough, or choking after non-ear-nose-throat operations.
Hangzhou, ZhejiangAges Any age - NCT03365609Recruiting
Testing different treatment plans for H. pylori in children
This study compares four ways to treat H. pylori (a stomach germ) in children, to see which works best. It may help families by finding more effective or tolerable treatment options.
Shanghai, Shanghai MunicipalityAges 6–18 - NCT06852287RecruitingPhase 2
Study of chemo, targeted therapy, and immunotherapy for bile duct and gallbladder cancer
This trial tests a combination of chemotherapy directly to the liver, a targeted therapy pill, and an immunotherapy drug for people with advanced bile duct or gallbladder cancer that cannot be surgically removed. The goal is to see if this triple therapy can shrink or control the cancer.
Tianjin, TiaAges 18 years+ - NCT07349758RecruitingPhase 1
Single dose of two PrEP tablets in healthy volunteers
This study tests how taking two tablets of a PrEP medication (F/TAF) at once affects healthy volunteers. It helps us understand the safety and how the body processes the drug.
Baltimore, MarylandAges 18 years+ - NCT07343037Recruiting
Diagnosing overactive immune response in ICU patients
This study is looking at patients who were in the intensive care unit and showed signs of a condition called HLH, where the immune system becomes overactive. Researchers want to understand how these signs were diagnosed and managed in the ICU.
StrasbourgAges 18 years+ - NCT07340151Recruiting
Surgery for limited liver or lung pancreatic cancer spread
This trial tests whether removing or ablating limited liver or lung tumors from pancreatic cancer that has not spread elsewhere, along with a specific chemotherapy (NALIRIFOX), can help patients. It is for people who have not had any previous cancer treatment.
San Antonio, TexasAges Any age - NCT07337993Recruiting
Fungal chest infection: washing the chest cavity
This study tests a chest-washing procedure (lavage) for people with a fungal infection in the space between the lung and chest wall. It aims to see if this extra step helps clear the infection before or instead of surgery.
Lahore, Punjab ProvinceAges Any age - NCT07337421RecruitingPhase 2
Chemo infusion after liver cancer surgery to lower recurrence risk
This trial tests whether a targeted chemotherapy infusion directly into the liver's main artery (HAIC) after surgery can prevent liver cancer from coming back. It is for people with certain high-risk features, like a large tumor or cancer in blood vessels, who have had their tumor completely removed.
Yangzhou, JiangsuAges 18–75 - NCT07333612Recruiting
Evaluating inactive liver cysts in echinococcosis
This trial looks at people with inactive liver cysts caused by echinococcus infection. It aims to understand these cysts better, which might help guide future care decisions.
Pavia, PVAges 18 years+ - NCT07326865Recruiting
Sugar metabolism study in obese patients with and without MASLD
This study looks at how the liver responds to sugar given through a vein in obese patients with and without a fatty liver condition called MASLD. It may help doctors understand why some people develop liver problems from sugar and fat.
Amsterdam, North HollandAges 35–65 - NCT06812390RecruitingPhase 2
Albumin plus diuretics for cirrhosis-related leg swelling
This study tests whether giving albumin (a protein) along with water pills helps reduce leg swelling in people with cirrhosis and ascites. It may be an option if your leg swelling hasn't improved with standard diuretics alone.
West Haven, ConnecticutAges 18 years+ - NCT07319299Enrolling by invitation
Liver cancer screening study for people with chronic liver disease
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
Bangkoknoi, BangkokAges 18 years+ - NCT07317011Recruiting
Active referral for hepatitis B patients
This trial aims to connect adults with chronic hepatitis B to proper care. It tests an active referral program for patients hospitalized in specific departments in Bergamo, Italy, or attending certain clinics, to see if it improves follow-up and treatment.
BergamoAges 18–100 - NCT07306988RecruitingPhase 4
Treating H. pylori to improve metabolic syndrome
This trial tests whether treating H. pylori infection can help improve metabolic syndrome (a group of conditions like high blood sugar, abnormal cholesterol, and high blood pressure). It aims to understand how treatment changes your gut bacteria and overall health.
Nanjing, JiangsuAges 18–65 - NCT07306156RecruitingPhase 1/Phase 2
GP350 CAR-T for Epstein-Barr virus related lymphoma
This trial tests a new treatment called GP350 CAR-T for patients with lymphoma (a type of blood cancer) that has come back or not responded to standard therapy, especially when linked to Epstein-Barr virus (EBV) infection. The therapy uses your own immune cells, modified to target and kill cancer cells carrying the GP350 protein from EBV.
Hefei, AnhuiAges 18–70 - NCT07301320RecruitingPhase 2
Epetraborole for Mycobacterium abscessus lung infection
This study tests an investigational medication called epetraborole for people with a chronic lung infection caused by Mycobacterium abscessus bacteria. You may be able to join if your infection is stable enough to delay standard treatment and you have symptoms like cough, fatigue, or weight loss.
Portland, OregonAges 18 years+ - NCT05385237Recruiting
4D MRI scan to spot liver scarring
This study tests whether a special MRI scan (called 4D-MRI) can identify liver scarring or damage. It may help doctors measure liver fibrosis and inflammation without relying only on invasive tests.
Liestal, Basel-LandschaftAges 18 years+ - NCT07282093RecruitingPhase 1
Olverembatinib in people with liver problems
This trial tests how a drug called olverembatinib is processed by the body in people with different levels of liver impairment. It looks at how the liver condition affects the drug levels and safety, which may help find the right dose.
Suzhou, JiangsuAges 18–75 - NCT07286370RecruitingPhase 2
Vaccine study for typhoid and salmonella in infants
This study tests a new vaccine that could protect infants against typhoid fever and a serious type of salmonella. If your baby is healthy and within the age range, they may be eligible to participate.
BanjulAges 1 month–6 months
Hear when a new Sexually Transmitted Infections (Not HIV or Hepatitis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for sexually transmitted infections (not hiv or hepatitis)?
- Yes. Clin2 currently lists 778 recruiting sexually transmitted infections (not hiv or hepatitis) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a sexually transmitted infections (not hiv or hepatitis) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a sexually transmitted infections (not hiv or hepatitis) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.